Bayforest Capital’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-6,937
Closed -$135K – 1165
2026
Q2
$135K Buy
6,937
+726
+12% +$14.4K 0.13% 312
2026
Q1
$119K Buy
+6,211
New +$122K 0.13% 302
2025
Q4
– Sell
-1,040
Closed -$19.4K – 938
2025
Q3
$19.4K Buy
1,040
+524
+102% +$9.8K 0.01% 648
2025
Q2
$9.5K Sell
516
-10,144
-95% -$180K ﹤0.01% 634
2025
Q1
$186K Buy
10,660
+5,313
+99% +$89.6K 0.08% 402
2024
Q4
$92.6K Buy
+5,347
New +$97.6K 0.12% 329

Other funds holding SBRA

Bayforest Capital's SBRA Position: Q3 2026 in Review

Bayforest Capital sold out of Sabra Healthcare REIT (SBRA) in Q3 2026, closing a stake of 6,937 shares — an estimated $135K sold.

Bayforest Capital first reported a position in SBRA in Q4 2024 and held it in 6 quarters. The position peaked at $186K in Q1 2025. 254 funds tracked by Wall St. Rank hold SBRA as of Q3 2026.

  • Bayforest Capital reported no remaining Sabra Healthcare REIT position as of Q3 2026 after selling out during the quarter.
  • Bayforest Capital sold 6,937 Sabra Healthcare REIT shares in Q3 2026, an estimated $135K.
  • Bayforest Capital first reported a position in Sabra Healthcare REIT in Q4 2024 and held it in 6 quarters.
  • Bayforest Capital's Sabra Healthcare REIT position peaked at $186K in Q1 2025.
  • 254 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2026.

Based on Bayforest Capital's 13F filing for Q3 2026, filed 3 Nov 2026.